ATE317395T1 - Aktivatoren für die oligonukleotidsynthese - Google Patents

Aktivatoren für die oligonukleotidsynthese

Info

Publication number
ATE317395T1
ATE317395T1 AT02748994T AT02748994T ATE317395T1 AT E317395 T1 ATE317395 T1 AT E317395T1 AT 02748994 T AT02748994 T AT 02748994T AT 02748994 T AT02748994 T AT 02748994T AT E317395 T1 ATE317395 T1 AT E317395T1
Authority
AT
Austria
Prior art keywords
activators
oligonucleotide synthesis
oligonucleotide
synthesis
Prior art date
Application number
AT02748994T
Other languages
English (en)
Inventor
Nanda Sinha
William Edward Zedalis
Gregory Keith Miranda
Original Assignee
Avecia Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avecia Biotechnology Inc filed Critical Avecia Biotechnology Inc
Application granted granted Critical
Publication of ATE317395T1 publication Critical patent/ATE317395T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/18Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02748994T 2001-07-03 2002-07-01 Aktivatoren für die oligonukleotidsynthese ATE317395T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30271701P 2001-07-03 2001-07-03

Publications (1)

Publication Number Publication Date
ATE317395T1 true ATE317395T1 (de) 2006-02-15

Family

ID=23168928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02748994T ATE317395T1 (de) 2001-07-03 2002-07-01 Aktivatoren für die oligonukleotidsynthese

Country Status (16)

Country Link
US (2) US7501505B2 (de)
EP (1) EP1404696B1 (de)
JP (1) JP4574167B2 (de)
KR (1) KR100898083B1 (de)
CN (1) CN100430411C (de)
AR (1) AR036122A1 (de)
AT (1) ATE317395T1 (de)
CA (1) CA2452205C (de)
DE (1) DE60209128T2 (de)
DK (1) DK1404696T3 (de)
ES (1) ES2258151T3 (de)
HU (1) HUP0400151A2 (de)
IL (1) IL159402A0 (de)
PL (1) PL367623A1 (de)
RU (1) RU2004102903A (de)
WO (1) WO2003004512A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036122A1 (es) 2001-07-03 2004-08-11 Avecia Biotechnology Inc Un complejo de sal que comprende un n-alquilimidazol y una 1,1-dioxo-1,2-dihidro-1l6-benzo [d]-isotiazol-3-ona y un metodo para sintetizar oligonucleotidos utilizando la quimica de fosforamidita
DE60313993T2 (de) * 2002-10-15 2008-01-24 Avecia Biotechnology, Inc., Milford Verfahren zur phosphithylierung
GB0229443D0 (en) 2002-12-18 2003-01-22 Avecia Ltd Process
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US7339052B2 (en) * 2005-02-08 2008-03-04 Honeywell International Inc. Phosphoramidite activator for oligonucleotide synthesis
EP1874792B1 (de) 2005-04-27 2016-04-13 Sigma-Aldrich Co. LLC Aktivatoren für die oligonukleotid- und phosphoramiditsynthese
WO2009007736A1 (en) * 2007-07-12 2009-01-15 Avecia Biotechnology Inc. Oxidation process
KR200457843Y1 (ko) * 2010-05-26 2012-01-10 김원제 향기 발산 기능을 가지는 악취 차단 커버
CA2805546A1 (en) * 2010-06-30 2012-01-05 Girindus America, Inc. A new method of using n-thio compounds for oligonucleotide synthesis
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
CN104278030A (zh) * 2013-07-05 2015-01-14 上海交通大学医学院 小分子化合物Antagomir-31制备方法及应用
UA123995C2 (uk) 2015-08-05 2021-07-07 ЕЙСАЙ Ар ЕНД Ді МЕНЕДЖМЕНТ КО., ЛТД. Хіральні реагенти для одержання гомогенних олігомерів
US10072261B1 (en) * 2016-03-25 2018-09-11 Agilent Technologies, Inc. Double coupling method for oligonucleotide synthesis
CN110023321A (zh) 2016-08-17 2019-07-16 索尔斯蒂斯生物有限公司 多核苷酸构建体
US11597744B2 (en) 2017-06-30 2023-03-07 Sirius Therapeutics, Inc. Chiral phosphoramidite auxiliaries and methods of their use
WO2019158007A1 (zh) * 2018-02-13 2019-08-22 深圳华大生命科学研究院 合成寡核苷酸的方法及系统
CN113993876B (zh) * 2019-06-11 2024-06-14 豪夫迈·罗氏有限公司 使用改进的氧化方案制备寡核苷酸的方法
JPWO2021141072A1 (de) * 2020-01-08 2021-07-15

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US757650A (en) * 1903-09-30 1904-04-19 Wilfrid Chausse Means for cleaning the third rails of electrical railways.
US3325475A (en) * 1964-11-16 1967-06-13 Maumee Chemical Company Organic amine salts of saccharin
JPS4822628B1 (de) * 1967-04-15 1973-07-07
IT8148047A0 (it) * 1981-03-18 1981-03-18 Manetti & Roberts Italo Brit Composti organici derivati da 2-ami no-5-(o-solfamidofenil)-1,3,4-tiadiazolo loro applicazione terapeutica e procedimento per la loro preparazione
DE3430805A1 (de) * 1984-03-08 1985-09-19 Bayer Ag, 5090 Leverkusen Mikrobizide mittel
DE3639901A1 (de) * 1986-11-22 1988-06-01 Bayer Ag Saccharin-salze von substituierten aminen
US5034534A (en) * 1988-07-15 1991-07-23 E. I. Du Pont De Nemours And Company Process for producing saccharin, saccharin analogues or their salts
JPH04330093A (ja) * 1990-07-20 1992-11-18 Takeda Chem Ind Ltd オリゴリボヌクレオチドの製造法
US5639875A (en) 1995-02-01 1997-06-17 Hybridon, Inc. Methods for H-phosphonate syntheis of oligonucleotides using triphosgene
WO1998016540A1 (en) * 1996-10-15 1998-04-23 Proligo Llc Improved coupling activators for oligonucleotide synthesis
US5896999A (en) 1996-10-16 1999-04-27 United Parcel Service Of America, Inc. Sorting system
US5955600A (en) * 1996-12-27 1999-09-21 Isis Pharmaceuticals, Inc. Method for the synthesis of nucleotide or oligonucleotide phosphoramidites
US6096881A (en) 1997-05-30 2000-08-01 Hybridon, Inc. Sulfur transfer reagents for oligonucleotide synthesis
US6274725B1 (en) * 1998-06-02 2001-08-14 Isis Pharmaceuticals, Inc. Activators for oligonucleotide synthesis
AR036122A1 (es) 2001-07-03 2004-08-11 Avecia Biotechnology Inc Un complejo de sal que comprende un n-alquilimidazol y una 1,1-dioxo-1,2-dihidro-1l6-benzo [d]-isotiazol-3-ona y un metodo para sintetizar oligonucleotidos utilizando la quimica de fosforamidita
DE60313993T2 (de) * 2002-10-15 2008-01-24 Avecia Biotechnology, Inc., Milford Verfahren zur phosphithylierung
GB0229443D0 (en) * 2002-12-18 2003-01-22 Avecia Ltd Process

Also Published As

Publication number Publication date
HUP0400151A2 (en) 2007-08-28
DE60209128D1 (de) 2006-04-20
DE60209128T2 (de) 2006-10-05
US20060041114A1 (en) 2006-02-23
AR036122A1 (es) 2004-08-11
JP4574167B2 (ja) 2010-11-04
WO2003004512A1 (en) 2003-01-16
CA2452205C (en) 2011-11-08
IL159402A0 (en) 2004-06-01
ES2258151T3 (es) 2006-08-16
US20090085006A1 (en) 2009-04-02
US7501505B2 (en) 2009-03-10
CN1549820A (zh) 2004-11-24
CA2452205A1 (en) 2003-01-16
US8093397B2 (en) 2012-01-10
EP1404696B1 (de) 2006-02-08
KR100898083B1 (ko) 2009-05-18
PL367623A1 (en) 2005-03-07
KR20040015758A (ko) 2004-02-19
DK1404696T3 (da) 2006-06-06
JP2004533488A (ja) 2004-11-04
EP1404696A1 (de) 2004-04-07
CN100430411C (zh) 2008-11-05
RU2004102903A (ru) 2005-07-10

Similar Documents

Publication Publication Date Title
DE60209128D1 (de) Aktivatoren für die oligonukleotidsynthese
DE60332760D1 (de) Zusammensetzungen für die ernährung
DE60329381D1 (de) Organ-retraktor für die endoskopie
ATE298778T1 (de) Fischer-tropsch-syntheseverfahren
DE60216572D1 (de) Katalysator für die wasserstofferzeugung und katalysator für die abgasreinigung
PL376511A1 (pl) Acetylo 2-hydroksy-1,3-diaminoalkany
AU2003224897A8 (en) Oligonucleotide probes for genosensor chips
ATE329718T1 (de) Giessformanordnung für exothermisches schweissen
DK1480743T3 (da) Fischer-Tropsch understöttet katalysator-aktivering
DE60141316D1 (de) Indikator für die plasmasterilisation
EP1634645A4 (de) Katalysator für die acrylnitril-synthese
AU2003234301A8 (en) Diamond synthesis
EP1497027A4 (de) Fischer-tropsch-katalysator
DK1379605T3 (da) Katalysatoraktiveringsfremgangsmåde
GB0120366D0 (en) Nanostructure synthesis
ATE360674T1 (de) Hydrierverfahren
DE60236049D1 (de) Elektroakustische Umwandlung für Fahrzeuge
DE60211934D1 (de) Kupplung für rückhalterung
DE60227336D1 (de) Bremsbelag für Bremse
ITMI20020415A1 (it) Catalizzatori metallici per reazione chemo- regio- stereo-selettive erelativi precursori
DE60329834D1 (de) Auffrischschema für die dynamische seitenprogrammierung
DE50203483D1 (de) Vanadium-Imido-Phosphoraniminato-Komplexe für die Olefinpolymerisation
DE60216885D1 (de) Prozessor für die Befehlszeilenschnittstelle
ATE289987T1 (de) Integriertes kohlenwasserstoffsyntheseverfahren
DE50301369D1 (de) Kuvertierstation für postbearbeitungssysteme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties